Business · 09/04/2024
FDA Clears NALFON Oral Capsules for Sale
The FDA has ruled that NALFON (Fenoprofen Calcium) oral capsules, equivalent to 300 milligram base, and other drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing them to continue being approved for use in abbreviated new drug applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →